ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.

Lijuan Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.